GLEN CLOVA SCIENTIFIC LIMITED

Active Glasgow

Research and experimental development on biotechnology

12 employees website.com
Research and experimental development on biotechnology
G

GLEN CLOVA SCIENTIFIC LIMITED

Research and experimental development on biotechnology

Founded 27 Sept 2022 Active Glasgow, Scotland 12 employees website.com
Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 3 months remaining
Confirmation
Net assets £2M £2M 2024 year on year
Total assets £2M £2M 2024 year on year
Total Liabilities £83K £49K 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

272 Bath Street Glasgow Lanarkshire G2 4JR Scotland

Website

www.example.com

Full company profile for GLEN CLOVA SCIENTIFIC LIMITED (SC745604), an active company based in Glasgow, Scotland. Incorporated 27 Sept 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£2.04M

Increased by £2.04M (+2022915%)

Net Assets

£2.16M

Increased by £2.20M (+6815%)

Total Liabilities

£82.91k

Increased by £49.21k (+146%)

Turnover

N/A

Employees

12

Debt Ratio

4%

Decreased by 2272 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

27 Allotments 5,027,114 Shares £5.44m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Jun 202518,232£21k£1.17
1 Apr 2025201,960£236k£1.17
1 Apr 2025108,748£127k£1.17
1 Apr 2025201,960£236k£1.17
1 Apr 2025108,748£127k£1.17

Officers

Officers

1 active 2 resigned
Status
John Paul FoersterDirectorGermanUnited Kingdom5927 Sept 2022Active

Shareholders

Shareholders (26)

Norcliffe Nominees Limited
44.5%
2,129,478
John Paul Foerster
12.5%
600,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased
Active
Notified 4 Apr 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

John Paul Foerster

Ceased 4 Apr 2024

Ceased

Steven John Powell

Ceased 4 Apr 2024

Ceased

Dr Steven John Powell

Ceased 4 Apr 2024

Ceased

Group Structure

Group Structure

GLEN CLOVA SCIENTIFIC LIMITED Current Company

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 May 2026MortgageMortgage Satisfy Charge Full
8 Apr 2026ResolutionResolutions
7 Apr 2026CapitalAllotment of shares (GBP 500.9286) on 2 Apr 2026
1 Apr 2026OfficersTermination of Steven John Powell as director on 1 Apr 2026
1 Apr 2026OfficersChange to director Mr Jamie Cruickshank Hodgson on 1 Apr 2026
22 May 2026 Mortgage

Mortgage Satisfy Charge Full

8 Apr 2026 Resolution

Resolutions

7 Apr 2026 Capital

Allotment of shares (GBP 500.9286) on 2 Apr 2026

1 Apr 2026 Officers

Termination of Steven John Powell as director on 1 Apr 2026

1 Apr 2026 Officers

Change to director Mr Jamie Cruickshank Hodgson on 1 Apr 2026

Recent Activity

Latest Activity

Mortgage Satisfy Charge Full

2 weeks ago on 22 May 2026

Resolutions

1 months ago on 8 Apr 2026

Allotment of shares (GBP 500.9286) on 2 Apr 2026

1 months ago on 7 Apr 2026

Termination of Steven John Powell as director on 1 Apr 2026

2 months ago on 1 Apr 2026

Change to director Mr Jamie Cruickshank Hodgson on 1 Apr 2026

2 months ago on 1 Apr 2026